AU2001293891A1 - New combination for the treatment of asthma - Google Patents

New combination for the treatment of asthma

Info

Publication number
AU2001293891A1
AU2001293891A1 AU2001293891A AU9389101A AU2001293891A1 AU 2001293891 A1 AU2001293891 A1 AU 2001293891A1 AU 2001293891 A AU2001293891 A AU 2001293891A AU 9389101 A AU9389101 A AU 9389101A AU 2001293891 A1 AU2001293891 A1 AU 2001293891A1
Authority
AU
Australia
Prior art keywords
asthma
treatment
new combination
new
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001293891A
Other languages
English (en)
Inventor
Mika Karhu
Terhi Mattila
Esa Muttonen
Marjaana Siirila
Virpi Valkama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Oyj filed Critical Orion Oyj
Publication of AU2001293891A1 publication Critical patent/AU2001293891A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
AU2001293891A 2000-10-02 2001-10-01 New combination for the treatment of asthma Abandoned AU2001293891A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20002177A FI20002177A0 (fi) 2000-10-02 2000-10-02 Uusi yhdistelmä astman hoitoon
FI20002177 2000-10-02
PCT/FI2001/000854 WO2002028368A1 (en) 2000-10-02 2001-10-01 New combination for the treatment of asthma

Publications (1)

Publication Number Publication Date
AU2001293891A1 true AU2001293891A1 (en) 2002-04-15

Family

ID=8559216

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001293891A Abandoned AU2001293891A1 (en) 2000-10-02 2001-10-01 New combination for the treatment of asthma

Country Status (3)

Country Link
AU (1) AU2001293891A1 (fi)
FI (1) FI20002177A0 (fi)
WO (1) WO2002028368A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
AU2003293833B2 (en) 2002-12-12 2009-10-01 Covis Pharma B.V. Combination medicament
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
GB0315889D0 (en) * 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
PL1670482T5 (pl) 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
WO2006086270A1 (en) 2005-02-10 2006-08-17 Glaxo Group Limited Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
EP1982709A1 (en) * 2007-04-19 2008-10-22 CHIESI FARMACEUTICI S.p.A. Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
EP2080508A1 (en) * 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Dry powder formulation comprising an anticholinergic drug
TR201802969T4 (tr) * 2013-07-01 2018-03-21 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Yeni inhalasyon formülasyonları.
US20190076607A1 (en) 2017-09-13 2019-03-14 Lupin Atlantis Holdings Sa Inhaler and mesh for an inhaler

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
CN1149076C (zh) * 1997-03-20 2004-05-12 先灵公司 粉末附聚物的制备方法
CA2411047C (en) * 2000-05-22 2009-08-04 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers

Also Published As

Publication number Publication date
WO2002028368A1 (en) 2002-04-11
FI20002177A0 (fi) 2000-10-02

Similar Documents

Publication Publication Date Title
AU2002223827A1 (en) Well treatment
AU2002348135A1 (en) Methods for the treatment of addiction
AU2002224927A1 (en) Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
AU2002223028A1 (en) Inhaler
AU2002359163A1 (en) New use
AU2001272852A1 (en) Composition for the treatment of migraine
AU2002219229A1 (en) Means for the diagnosis and therapy of CTCL
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2001285747A1 (en) Method for the treatment of tobacco
AU2001293891A1 (en) New combination for the treatment of asthma
AU2001260834A1 (en) The treatment of herpes
AU2002335667A1 (en) Modified reoviral therapy
AU2001285156A1 (en) Combination therapy for the treatment of migraine
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
AU2002329441A1 (en) Process for the preparation of 3 - isochromanone
AU2001261324A1 (en) Psoriasis treatment
AU2003269257A1 (en) Use of cap-1 for the therapy of asthma
AU2002358085A1 (en) Process for the preparation of 4-methyl-7-aminoquinolones
AU3071899A (en) Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
AU2002256967A1 (en) Treating or reducing the risk of cardiovascular disease
AU2000272704A1 (en) Use of compounds for the treatment of obesity
AU2001253560A1 (en) Methods of treatment
AU2001292897A1 (en) Novel therapy
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides